Compass Diversified Holdings has announced that Alan Offenberg, who has served as interim CEO since February 17, 2011, has been elected by the company's board as CEO, and will remain on the company's board of directors. Compass Diversified Holdings owns and manages a portfolio of North American middle market businesses.
4 min read · 03 December 2012
VetDC has completed a $1.5 million private financing. VetDC is a Colorado State University veterinary biotechnology startup headquartered in Fort Collins, Colorado.
2 min read · 03 December 2012
Equistone Partners Europe has sold ATPI to its management, backed by Intermediate Capital Group for an undisclosed amount. ATPI is a global travel management service provider with operations in business travel, corporate event management and online travel technology.
2 min read · 03 December 2012
UK-based Business Growth Fund has invested 6.25 million pounds ($10 million) of growth capital for a minority stake in London-based Peyton and Byrne. The restaurant group is a retail bakery and events business.
5 min read · 03 December 2012
UK mid market buyout house Dunedin has backed the management buyout of Premier Hytemp, a manufacturer of engineered alloy components for the offshore and onshore oil and gas industry. The business was acquired from Murray International Holdings, in a 34.5 million pounds ($55.3 million) transaction.
4 min read · 03 December 2012
Quay Partners has appointed Angus Whiteley as group CEO, based in London. Whiteley comes from a private equity direct investment background. He is a law graduate of Cambridge University. Quay Partners is an independent private equity and infrastructure manager and advisor with offices in London, Sydney, San Francisco and Boston.
3 min read · 03 December 2012
This morning First Read brings you the latest Asia deals round-up, revelations that biotech Can Do it and marks twenty years since the first SMS was sent.
1 min read · 03 December 2012
Rib-X Pharmaceuticals has closed the first tranche of a $67.5 million Series 2 preferred stock financing. A second tranche is anticipated to close around the end of 2012. The round was led by new investor Vatera Healthcare Partners and included existing shareholders Warburg Pincus, ABS Ventures and Vox Equity Partners.
4 min read · 29 November 2012
Biopharmaceutical company NanoBio has closed an $11 million Series C financing. The company’s lead product candidates are treatments for herpes labialis, onychomycosis, vaginitis, cystic fibrosis and a broad platform of nanoemulsion-based vaccines. The company’s headquarters and laboratory facilities are located in Ann Arbor, Michigan.
2 min read · 29 November 2012
Ares Management has announced the successful initial public offering of Ares Dynamic Credit Allocation Fund. The fund priced an offering of 16 million shares at a price of $20.00 per share, for a total issuance of $320 million. Shares will commence trading today on the New York Stock Exchange (NYSE) under the symbol ARDC.
3 min read · 29 November 2012
